ADVM-022 Intravitreal Gene Therapy for DME

Clinical trial NCT04418427 · COMPLETED

Trial details

NCT number: NCT04418427
Sponsor: Adverum Biotechnologies, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Macular Edema Diabetic Retinopathy

Start date: 2020-05-28
Primary completion: 2022-11-22
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.